Targeting polyamine as a novel therapy in xenograft models of malignant pleural mesothelioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting polyamine as a novel therapy in xenograft models of malignant pleural mesothelioma

Published:2020-10 Issue: Volume:148 Page:138-148
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Lam Sze-Kwan,Yan Sheng,Xu Shi,Ho James Chung-Man

Funder

Hong Kong Pneumoconiosis Compensation Fund Board

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference56 articles.

1. Pathologic evaluation of malignant pleural mesothelioma;Chirieac;Semin. Thorac. Cardiovasc. Surg.,2009

2. Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population;Flores;J. Thorac. Oncol.,2010

3. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma;Scherpereel;Eur. Respir. J.,2020

4. Spermidine as a target for cancer therapy;Fan;Pharmacol. Res.,2020

5. Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury;Noro;Cell Death Dis.,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disturbance of the Warburg effect by dichloroacetate and niclosamide suppresses the growth of different sub-types of malignant pleural mesothelioma in vitro and in vivo;Frontiers in Pharmacology;2022-10-11

2. Polyamines: Functions, Metabolism, and Role in Human Disease Management;Medical Sciences;2021-06-09

3. Radical Hemithoracic Radiotherapy Induces Systemic Metabolomics Changes That Are Associated with the Clinical Outcome of Malignant Pleural Mesothelioma Patients;Cancers;2021-01-29

4. Mouse models for mesothelioma drug discovery and development;Expert Opinion on Drug Discovery;2020-12-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3